CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 92 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03440905
NCT03440905N/ACompleted
CompareCT.gov

Proxy-Reported Symptoms and Quality of Life Survey in Zellweger Spectrum Disorders

University of South Florida·observational·Posted Feb 22, 2018·Updated Oct 16, 2019

In Brief

An observational study for Zellweger Spectrum. Completed, enrolled 92 participants across 1 site.

Detailed Summary

The purpose of this study is to characterize the symptoms of Zellweger Spectrum Disorder (ZSD) and related peroxisome disorders, and to assess the quality of life of family caregivers (parents, stepparents, legal guardians) of patients diagnosed with ZSD or a related peroxisome disorder. All family caregivers of patients enrolled in the Rare Diseases Clinical Research Network (RDCRN) Contact Registry who are diagnosed with ZSD or a related peroxisome disorder will be invited via email to participate in this study.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsZellweger Spectrum
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), Montclair State University, University of Nebraska

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedFeb 22, 2018
Enrollment StartJan 29, 2018
Primary CompletionNov 30, 2018
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 8.4 years ago